Chemical composition and antioxidant activity of aerial parts of Ferula longipes Coss. ex Bonnier and Maury

This is the first study on the phytochemistry and antioxidant activity of Ferula longipes Coss. ex Bonnier and Maury (Apiaceae). A new flavonoid quercetin-3-O-α-L-rhamnopyranoside-7-O-ß-D-[2-O-caffeoyl]-glucopyranoside (1), along with 10 known compounds kaempferol-3-O-α-L-rhamnopyranoside (2), quercetin-3-O-α-L-rhamnopyranoside (3), kaempferol-3-O-ß-D-glucopyranoside-7-O-α-L-rhamnopyranoside (4), isorhamnetin-3-O-α-L-rhamnopyranoside-7-O-ß-D-glucopyranoside (5), quercetin-3-O-α-L-rhamnopyranoside-7-O-ß-D-glucopyranoside (6), isorhamnetin-3,7-di-O-β-D-glucopyranoside (7), apigenin (8), apigenin-7-O-ß-D-glucopyranoside (9), 3,5-dicaffeoylquinic acid (10), deltoin (11) were isolated from the aerial parts of Ferula longipes Coss. Structures elucidation was performed by comprehensive 1D and 2D NMR analyses, mass spectrometry and by comparison with literature data. The compounds 1, 3, 4, 6, 7 and 10 were evaluated for their antioxidant activity, compound 1 exhibited the best antiradical activity potential and showed IC₅₀ and A_0.5 values 5.70, 7.25, 5.00, and 2.63 μg/mL towards DPPH free radical-scavenging, ABTS, CUPRAC, and reducing power assays, respectively compared with BHA, BHT and ascorbic acid which were used as positive controls.     

Odorant Receptor 7D4 Activation Dynamics

Deciphering how an odorant activates an odorant receptor (OR) and how changes in specific OR residues affect its responsiveness are central to understanding our sense of smell. A joint approach combining site‐directed mutagenesis and functional assays with computational modeling has been used to explore the signaling mechanics of OR7D4. In this OR, a genetic polymorphism affects our perception of androstenone. Molecular simulations totaling 0.12 ms predicted that, similarly to observations for other G‐protein‐coupled receptors with known experimental structures, an activation pathway connects the ligand and the G‐protein binding site. The 3D model activation mechanism correlates with in vitro data and notably predicts that the OR7D4 WM variant is not activated. Upon activation, an OR‐specific sequence motif is the convergence point of the mechanism. Our study suggests that robust homology modeling can serve as a powerful tool to capture OR dynamics related to smell perception.     

Performance of electrolyte assays in the United Kingdom—reference target values

Wales External Quality Assessment Scheme (WEQAS) is one of the largest external quality assessment (EQA) providers in the United Kingdom, with over 600 participants. Over the last two and a half years, reference target values have been used for the electrolyte panel in the WEQAS General Chemistry scheme. Reference methods have a vital role in that they ensure the transfer of accuracy from definitive methods to routine methods. Validated reference methods, using flame emission/atomic absorption spectrometry were established for sodium, potassium, calcium, magnesium and lithium. These methods were validated by direct comparison with the definitive method via the use of primary reference material. Comparison against the all laboratory trimmed mean (ALTM) showed a small mixed systematic error for sodium and potassium, with a maximum bias from the reference value of 1% and 2%, respectively. Lithium and magnesium data showed predominant systematic constant errors of +0.03 and +0.02 mmol/l, respectively. For calcium, ALTM results showed a mixed systematic error with a cross over in the reference range (5% positive bias and constant error of –0.1 mmol/l). Over 40% of participants used the cresolpthalein complexone method, greatly influencing the ALTM value, (11% bias, constant error –0.26 mmol/l). Other methods such as the ion selective electrode (ISE) method were in closer agreement to the reference method (–4% bias, +0.05 mmol/l constant error). The study highlights the pitfalls of using the overall mean data as an accuracy target in EQA schemes.Presented at the 8th Conference on Quality in the Spotlight, 17–18 March 2003, Antwerp, Belgium     

Enzyme-linked flow-injection immunoassay using immobilized secondary antibodies

A fast, non-equilibrium enzyme-linked flow-injection immunoassay (FIIA) system using an immobilized secondary-antibody reactor is described. The assay method is based on the competition between the enzyme-labeled antigen and analyte (unlabeled antigen) for a limited amount of soluble primary-antibody binding sites. This mixture is then introduced via flow-injection into the secondaryantibody reactor. The reactor bound enzyme activity, as measured by flowing an appropriate substrate solution through the reactor, is inversely proportional to the concentration of free analyte in the sample. By using non-equilibrium conditions, a single assay takes a total time of 13 min or less including regeneration of the reactor. To illustrate the application of this system, theophylline and insulin were chosen as model hapten and macromolecule analytes, respectively. Preliminary studies suggest that the new FIIA system is suitable for determining theophylline in serum with acceptable accuracy and precision.     

Study of cerebrovascular reserve capacity by magnetic resonance perfusion weighted imaging and photoacoustic imaging

The aim of this work was to assess the feasibility of photoacoustic imaging (PAI) and MR imaging for evaluating the cerebrovascular reserve capacity (CVRC) in animal models. Wistar-Kyoto (WKY) rats and spontaneous hypertensive rats (SHR) were used for MRI. BALB/c mice were used for PAI. MR perfusion weighted imaging (PWI) was performed on a 1.5-T whole-body MR system before and after oral administration of acetazolamide (ACZ). The region of interest (ROI) was chosen in the bilateral frontal lobe for measuring regional cerebral blood flow (rCBF), regional cerebral blood volume (rCBV) and mean transit time (MTT). The vessel diameters of the superficial layer of the cortex were measured by PAI in the resting and ACZ-activated mice. The results showed that there was a statistical difference between the resting and ACZ-activated animals in vessel diameter, rCBV and rCBF values. The increments in rCBV and rCBF of WKY rats between resting and ACZ test states were significantly higher than that of SHR. The pathological findings of small arterial walls and lumen of the brain were also different between WKY and SHR rats. The diameters of blood vessels in the superficial layer of the brain measured by PAI were enlarged after the ACZ tolerance test. This result was also observed in the MRI CBV map, where the signal of the vessel in the superficial layer of the cortex became redder after the ACZ stimulation, suggesting the increase of blood flow. It can be concluded that MR PWI and PAI combined with the ACZ test might be useful in evaluating the CVRC and revealing the pathologic changes in cerebral vessels.     

Pyrimidines-Based Heterocyclic Compounds: Synthesis,Cytoxicity Evaluation and Molecular Docking

A variety of structurally different pyrimidines were synthesized. Elemental analysis, FT-IR, ¹H NMR, and ¹³C NMR spectroscopy were used to confirm the chemical structures of all prepared compounds. The synthesized pyrimidines were screened against the growth of five human cancer cell lines (prostate carcinoma PC3, liver carcinoma HepG-2, human colon cancer HCT-116, human breast cancer MCF-7, human lung cancer A-549), and normal human lung fibroblasts (MRC-5) using MTT assay. Most of the screened pyrimidines have anti-proliferative activity on the growth of the PC3 cell line. Compounds 3b and 3d were more potent than the reference vinblastine sulfate (~2 to 3 × fold) and they can be considered promising leads for treating prostate cancer disease. Moreover, the screened compounds 3b, 3f, 3g, 3h, and 5 were assessed according to the values of their selectivity index (SI) and were found to be more selective and safer than vinblastine sulfate. Furthermore, using in silico computational tools, the physicochemical properties of all pyrimidine ligands were assessed, and the synthesized compounds fall within the criteria of RO5, thus having the potential to be orally bioavailable.     

Polyphenolic Composition,Antioxidant, Antiproliferative and Antidiabetic Activities of Coronopus didymus Leaf Extracts

Coronopus didymus (Brassicaceae) commonly known as lesser swine cress has been reported to be used for its pharmacological activities. This study aimed to evaluate the medicinal potential of C. didymus extracts against cancer, diabetes, infectious bacteria and oxidative stress and the identification of bioactive compounds present in these extracts. The effects of using different solvents for the extraction of C. didymus on the contents of major polyphenols and biological activities were investigated. Plant sample was shade dried, ground to a fine powder, and then soaked in pure acetone, ethanol and methanol. The highest contents of major polyphenols were found in methanol-based extract, i.e., chlorogenic acid, HB acid, kaempferol, ferulic acid, quercetin and benzoic acid with 305.02, 12.42, 11.5, 23.33, 975.7 and 428 mg/g of dry weight, respectively, followed by ethanol- and acetone-based extracts. The methanol-based extract also resulted in the highest antioxidant activities (56.76%), whereas the highest antiproliferative (76.36) and alpha glucosidase inhabitation (96.65) were demonstrated in ethanol-based extracts. No antibacterial property of C. didymus was observed against all the tested strains of bacteria. Further studies should be focused on the identification of specific bioactive compounds responsible for pharmacological activities.     

5-巯基-1,3,4-噻二唑-2-硫酮微溶剂团簇的光谱和理论计算研究

微溶剂作用(即溶剂化过程)广泛存在于所有物理、 化学和生命过程中. 在液相化学反应体系中, 几乎是一切化学反应的基础. 通过傅里叶变换拉曼光谱(FT-Raman)并结合密度泛函理论(DFT), 表征了固态5-巯基- 1, 3, 4-噻二唑-2-硫酮(MTT)的结构, 并进一步确认了MTT在乙腈、 甲醇和水中微溶剂团簇的大小和氢键位点. 通过探究MTT在不同溶剂及pH条件下的紫外-可见吸收光谱(UV-Vis), 结合含时密度泛函理论(TD-DFT)计算, 揭示了溶剂和pH对MTT电子跃迁带的影响, 进一步解释了其光谱位移. 结合能量计算可以得出, MTT分别与1个乙腈、 2个甲醇和2个水分子形成MTT(CH₃CN), MTT(CH₃OH)₂ 和MTT(H₂O)₂团簇.     

Layer double hydroxides (LDHs)- based electrochemical and optical sensing assessments for quantification and identification of heavy metals in water and environment samples: A review of status and prospects

One of the most severe environmental problems is heavy metal contamination, putting the world's sustainability at risk. Much effort has been put into developing sensors that can be taken anywhere to detect the environmental effects of heavy metals. Sensitivity, selectivity, multiplexed detection ability, and mobility enhance significantly when nanoparticles and nanostructures are incorporated into sensors. LDHs (layered double hydroxides) have gotten much attention in analytical chemistry in recent years because of their benefits, including their large specific surface area, ease of synthesis, low cost, and high catalytic efficiency and biocompatibility. LDHs are often manufactured as nanomaterial composites or created with specialized three-dimensional structures depending on the application. However, in these settings, LDHs (as color indicators, extracting sorbents, and electrochemical sensing) are usually restricted. Upcoming signs of progress and development possibilities of LDHs in analytical chemistry are reviewed in this paper to assist overcome these problems. Furthermore, the approaches used in the design of LDHs, including structural aspects, are defined and assessed in preparation for future analytical applications. The latest advances in optical and electrochemical sensors to detect heavy metals are described in this review. The sorts and characteristics of LDHs will be explored first. We will then go into microelectrode (or nanoelectrode) arrays, nanoparticle-modified electrodes, and microfluidic optical and electrochemical sensing assays in detail. This paper also discusses design strategies for LDH-based nanostructured sensors and the advantages of using nanomaterials and nanostructures.     

Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity

BackgroundStreptokinase (SK) is a potent plasminogen activator naturally produced by beta-hemolytic streptococcus bacteria and used as a thrombolytic drug.ObjectivesOptimize high yield production of recombinant streptokinase (rSK) in Escherichia coli and evaluate its thrombolytic activity.MethodsSynthetic gene encoding mature SK protein with optimization for rare codons and mRNA secondary structure was cloned into the expression vector pET-3a and transformed into Escherichia coli BL21 (DE3). Seed banks were established for high rSK expression clones. The native rSK protein expression was optimized using IPTG induction. The nonsoluble rSK inclusion bodies were purified, denatured in 6 M guanidinium chloride, and refolded using the rapid dilution method. The refolded rSK protein was purified using anion exchange chromatography and evaluated with ELISA. The activity of rSK was evaluated using the casein digestion method and in vitro blood clot lysis assay with reference drug Sedonase as standard.ResultsSeed banks with high stable expression of native rSk (MW 47 kDa) were established. High rSK expression was optimized using 1 mM IPTG at bacterial OD600 0.6. The refolded rSK was prepared and purified successfully with high productivity (494 mg purified rsk/L culture). Using ELISA, the purified rSK molecular identity and conservation of native SK epitopes were confirmed. The enzymatic activity of the purified rSK was 1.945x10⁶ IU/mg with 62.94 ± 2.3% clot lysis efficiency.ConclusionA high yield production of proper rSK protein with in vitro thrombolytic activity similar to commercial SK has been achieved, suggesting a more cost-effective industrial production of its biosimilar drug.